14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:DMTX
Delisted

Dimension Therapeutics Fund Signals

$5.95
+0 (+0%)
At Close: Jan 16, 2018

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 31 days ( 0 % )
Last Price $5.95 0 %
High/ Low $5.95 - $5.95 0%
Chg 7 Days N/A $5.95 $5.95
Chg 30 Days N/A $5.95 $5.95
Chg 12 mos 23.96 % $4.80 $5.95
Trend - 3 mos -0.540 % Width: 0.86 %
Trend - 12 mos 168.18 % Width: 154.88 %
Pred. range - 3 mos $5.89 - $5.94 -1.02 % - -0.167 %
Pred. range - 12 mos $8.46 - $21.57 42.25 % - 262.55 %
Short MA avg 3 mos Buy Oct 26, 2017 - 49 days
Long MA avg 3 mos Buy Jan 04, 2018 - 9 days
Short/Long MA avg 3 mos Buy Jan 04, 2018 - 9 days
Short MA avg 12 mos Buy Oct 26, 2017 - 49 days
Long MA avg 12 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 12 mos Sell Nov 30, -1 - N/A days
Pivot Short Sell Nov 06, 2017 - 42 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Dimension Therapeutics

Dimension Therapeutics, Inc., a gene therapy platform company, focuses on discovering and developing therapeutic products for people living with rare diseases associated with the liver and caused by genetic mutations. The company's pipeline of programs includes DTX101, a lead gene therapy product candidate designed to deliver Factor IX, gene expression in patients with hemophilia B; DTX201, a gene therapy program for the treatment of hemophilia A... DMTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT